Ads
related to: modernatelmdfirst.com has been visited by 10K+ users in the past month
Search results
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 6 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. Following ...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 3 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 22 hours agoModerna (NASDAQ: MRNA) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 4 days agoFive years ago, pharmaceutical company Moderna (NASDAQ: MRNA) was mostly unknown. It was developing...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 3 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 3 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 3 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via Yahoo News· 3 days agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...